Earnings · China A-shares
Chongqing Jiheng Pharmaceutical Co., Ltd. Class A (002742) earnings
Chongqing Jiheng Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-28: net profit +85.02% year on year, +85.32% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -2.58% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- +85.02%
- Excl. one-offs YoY
- +85.32%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -2.29% | — |
| 3 days | -2.58% | — |
| 7 days | -1.15% | — |
| 14 days | -3.44% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 2 of 7 reports (average -2.43%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | -¥26.62M | +85.02% | +85.32% | -54.65% | -0.04 | -17.17% | -2.58% | — | — |
| 2026 interim report | 2026-08-15 | -¥20.14M | +84.62% | +84.37% | -50.51% | -0.03 | -12.72% | +0.47% | -3.98% | +2.62% |
| 2026 Q1 report | 2026-04-25 | -¥8.07M | +90.20% | +89.55% | -39.60% | -0.01 | -4.91% | -2.30% | -20.71% | -20.41% |
| 2025 annual report | 2026-03-31 | -¥419.68M | +35.45% | +34.40% | -24.74% | -0.61 | -67.51% | -1.99% | +2.65% | -5.76% |
| 2025 Q3 report | 2025-10-29 | -¥177.75M | -344.30% | -11.75% | -25.24% | -0.41 | — | +0.21% | -2.26% | +1.21% |
| 2025 interim report | 2025-08-27 | -¥130.98M | -97.02% | — | -33.89% | -0.30 | — | -5.04% | -3.15% | -6.93% |
| 2025 Q1 report | 2025-04-26 | -¥82.38M | -132.59% | — | -32.52% | -0.19 | — | -5.78% | +21.20% | +17.96% |
| 2024 annual report | 2025-04-26 | -¥650.13M | -43.82% | -73.13% | -41.10% | -0.95 | — | -5.78% | +21.20% | +17.96% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.